Hanover is monitoring the evolving landscape of federal and foundation grants in light of the new presidential administration's priorities. Before applying to any federal program, be sure to check with your institution's grants office as well as the relevant program officer.
Below is a recap of research funding opportunitiesthat were recently announced, nationwide. While these alerts are intended to provide you with a broad-reaching overview of the opportunities available, we certainly want to hear if thereare specific opportunities that you would like to pursue. Please let your Content Director know if you have any questions or are interested in learning more.
Our Grant Alerts dashboard profiles relevant previously announced national-level funding opportunities, which can be sorted by type, agency/funder, and date. Also, your dedicated Content Director and Relationship Director are ready to help with custom research solutions to the challenges you are facing.
Quick Links to Opportunities
These links will take you directly to the websites of the grant opportunities.
The Congressionally Directed Medical Research Program initiative has announced a suite of funding opportunities pertaining to Rare Cancer research, Military Burn research, and Duchenne Muscular Dystrophy research, with more funding topics to come in the following weeks. For all three programs, a variety of funding tracks are offered, including early-career, pilot grants, and clinical trials.
The Exponentiating Mathematics (expMath) program aims to develop an AI collaborator to increase the rate of progress in mathematics by orders of magnitude. The program will also aim to develop new evaluation methods to assess the progress of AI systems towards professional mathematics.
Eligibility:
There are no eligibility restrictions.
Dates:
Abstracts are due very soon, by May 15, 2025. Proposals are due by July 8, 2025.
This program is a collaboration between the Office of Naval Research Global and the Singapore Ministry of Defence, addressing a joint Naval need identified by both organizations, who are seeking proposals that (1) define challenging and realistic maritime scene perception scenarios represented by real-world and/or synthetic data generated by sensors commonly found on UxV platforms, and (2) present innovative AI algorithms that can successfully operate on that representative data and determine operational context. Notably, this RFP is a new announcement that falls under the broader ONR Long-Range BAA.
This program aims to solicit leading-edge research from academic collaborators that currently do not have a relationship with AFRL/RW via existing contract/grant. However, AFRL/RW will consider all U.S. universities’ proposals. AFRL/RW intends to award short-term seedling projects in two research areas: (1) Bioprincipic Systems (Sensors, Processing, Control, and Materials) and (2) Weapon Autonomy and Control Technology Research.
The FRAXA Research Foundation aims to find specific treatments and ultimately a cure for Fragile X syndrome. The foundation invites applications for its clinical trial and curative therapies grants programs. Clinical trial grants are flexible in amount, structure, and duration. Applications may be submitted anytime for amounts up to $100,000 per year. All work must be directed specifically at Fragile X therapeutics.
Gilead will evaluate and support select programs that aim to address one or both of the following scientific objectives: (1) generate data to assess current HDV linkage to care practice; identify barriers; develop and implement novel approaches to enhance linkage to care; and (2) generate data to determine who should be tested or retested for anti-HDV antibody and/or HDV RNA and the optimal timing for retesting to ensure accurate diagnosis. Applications should include projects that can be completed within 18 months. This program will support individual projects up to $200,000.
This program supports the development of new approaches to restore/enhance function and prevent or alleviate complications that arise after traumatic SCI. Research should be designed to demonstrate an improvement in function or clinical decision-making. The inclusion of individuals with SCI in the design of studies to aid the development of research that leads to an improved quality of life is encouraged.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due by May 23, 2025.
Questions?
We'll be happy to help you find the right grants opportunity for your organization.
About Hanover Research: Founded in 2003, Hanover Research is a global research and grant development firm. The Hanover Grants practice provides research development, grant writing, and strategic advising support to a wide range of institutions and organizations. Our professionals deliver customized proposal review, revision, and production support, while also helping to align strategic priorities to funding trends and opportunities at all levels. To learn more about Hanover Research, visit www.hanoverresearch.com.
Hanover Research 4401 Wilson Blvd, 4th Floor Arlington VA 22203
You received this email because you are subscribed to Grant Alerts and Calendars from Hanover Research.
Update your email preferences to choose the types of emails you receive.
